Skip to content

Randomised controlled trial of Zonnic and nicotine patch (ZAP) in smoking cessation

Randomised placebo-controlled trial of Zonnic and nicotine patch in heavy smokers for smoking cessation

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000482268
Enrollment
1600
Registered
2009-06-18
Start date
2010-03-12
Completion date
2011-06-28
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We aim to test the effect on 12 month quit rates of adding Zonnic (a nicotine mouthspray) to nicotine patch therapy compared to nicotine patch therapy plus placebo Zonnic. Subjects will receive 5 months of nicotine patch, and 6 months of Zonnic. Subjects will reduce their smoking in the first month, then quit smoking and continue to use Zonnic and patches. Abstinence will be measured at 12 months post-cessationo and verified by plasma or hair nicotine.

Interventions

Zonnic (peppermit flavoured nicotine mouthspray) plus nicotine patch compared to placebo-Zonnic plus active nicotine patch. Zonnic for 6 months, nicotine patch for 5 months. Zonnic contains 1mg nicotine per spray, use at the discretion of the participant for first 5 months, wean during 6th month. Use patches daily with dose titrated to amount smoked using standard schedule recommended by manufacturer. In 5th month wean from patches in step-wise manner as laid out by manufacturer. Zonnic and patc

Zonnic (peppermit flavoured nicotine mouthspray) plus nicotine patch compared to placebo-Zonnic plus active nicotine patch. Zonnic for 6 months, nicotine patch for 5 months. Zonnic contains 1mg nicotine per spray, use at the discretion of the participant for first 5 months, wean during 6th month. Use patches daily with dose titrated to amount smoked using standard schedule recommended by manufacturer. In 5th month wean from patches in step-wise manner as laid out by manufacturer. Zonnic and patches both start at the second clinic visit. Quit date is the first quit day at the end of the 3 weeks of smoking reduction.

Sponsors

Health Research Council of New Zealand
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Smokers of 15 or more cigarettes per day, with Fagerstrom Test of Nicotine Dependence score of 3 or greater.

Exclusion criteria

Any serious medical condition, history of peptic ulcer, cardiovascular disease, pregnancy, breastfeeding, inadequate contraception.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026